Effectiveness and tolerability of Tonsilgon® N in the treatment of recurrent upper respiratory tract infections in children: a non-interventional study in Russia

Clinical Phytoscience

International Journal of Phytomedicine and Phytotherapy

Table 1 Distribution of patients and number of ARI in the last 6 months prior to enrolment

Age group	Gender	N	Number of acute upper respiratory tract infections
Age group	Gender	N	not recorded	once	twice	three times	four times	five times
2–5	female	131	2	1	95	27	4	2
2–5	male	138			101	28	7	2
6–11	female	120			103	16	1
6–11	male	127			113	12	2
	Total	516	2	1	412	83	14	4
	Total [%]	100.0	0.4	0.2	79.8	16.1	2.7	0.8